Gossamer Bio Inc (GOSS) - Monday, Aug 26, 2024
Gossamer Bio is developing seralutinib for PAH in Phase 3 clinical trials. Recent changes in C-suite, insider stock purchases, and partnerships...
S&P 500, Nasdaq 100 Testing Key Resistance Levels; Pause Likely; Buying Biotech
$SPX is testing important resistance in the 4165-4180 area, the same resistance level we were monitoring in early June before the market tumbled 13...
No more insights